NL-OMON21925招募中不适用
Pancreatic cancer: validation of circulating predictive biomarkers
Erasmus University Medical Center, department of Surgery0 个研究点目标入组 240 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 240
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Age = 18 years.
- •Diagnosed with (borderline) resectable, locally advanced or metastatic PDAC.
- •Treatment with FOLFIRINOX chemotherapy, including neoadjuvant therapy in the investigational group ór treatment with gemcitabine (with nab-paclitaxel) in the control group.
- •Written informed consent (either for PANCAKE in case of locally advanced PDAC and metastasized PDAC or for the PREOPANC-3 trial in case of (borderline) resectable PDAC).
排除标准
- •Combined treatment with other chemotherapeutics then FOLFIRINOX.
- •Previous treatment with FOLFIRINOX chemotherapy.
- •Pregnancy.
- •Serious concomitant systemic disorders that would compromise the safety of the patient or his/her ability to complete the study, at the discretion of the investigator.
研究者
相似试验
招募中
不适用
Pancreatic cancer: validation of circulating predictive biomarkerspancreatic cancerNL-OMON55991Erasmus MC, Universitair Medisch Centrum Rotterdam240
已完成
不适用
Comparing Newly Developed PreCore Needle With Conventional Fine Needle in Suspected Unresectable Pancreatic CancerPancreatic CancerNCT01876069Samsung Medical Center65
已完成
不适用
Prognostic and Predictive Biomarkers of Therapeutic Response in Pancreatic TumorsPancreatic TumorNCT01692873Institut Paoli-Calmettes274
进行中（未招募）
不适用
Verification of Predictive Biomarkers for Pancreatic Cancer Treatment Using Multicenter Liquid BiopsyPancreas AdenocarcinomaNCT04241367National Cancer Center, Korea420
已完成
不适用
A Longitudinal, Observational Biomarker Study in Pancreatic Cancer Patients Receiving ChemotherapyPancreatic CancerNCT04281511National Cancer Center, Korea238